Intestinal parasitic infections (IPIs) have been identified as a disease agent responsible for infections in immunocompromised patients such as diabetics. We searched six electronic databases and reviewed 38 related studies using the following keywords alone or in combination: "intestinal parasites", "diabetes", "immunocompromised", "prevalence", and "human." The pooled prevalence of IPIs in diabetic patients was 24.4% worldwide. These patients with IPIs are advised to go to health centers and perform the relevant checkups with the advent of the first symptoms of the disease, such as diarrhea and abdominal pain. Moreover, early diagnosis and treatment of IPIs in diabetic patients are highly recommended to maintain quality of life.
Keyphrases
- abdominal pain
- end stage renal disease
- risk factors
- ejection fraction
- type diabetes
- healthcare
- newly diagnosed
- endothelial cells
- public health
- cardiovascular disease
- chronic kidney disease
- glycemic control
- mental health
- peritoneal dialysis
- prognostic factors
- respiratory failure
- intensive care unit
- patient reported outcomes
- depressive symptoms
- adipose tissue
- physical activity
- big data
- acute respiratory distress syndrome
- study protocol
- sleep quality
- extracorporeal membrane oxygenation
- human health